Professor Gary Fooks
PhD, MA, LLB
Expertise
Current positions
Professor in Criminology
School for Policy Studies
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
Before joining the University of Bristol, I was a reader in Sociology at Aston University. Prior to that, I was at the University of Bath, where I worked on the corporate political activity of tobacco companies.
I welcome applications from PhD students in any of my research interests.
Research interests
My main research interests are in corporate harm, corporate power, and business regulation, particularly in field of the commercial determinants of health. My current projects centre on the stabilisation of corporate scientific knowledge, the deterrent effects of enforcement action against large businesses, elite welfare, and the civil and political ties of financial elites.
Before joining the University of Bristol, I was a reader in Sociology at Aston University. Prior to that, I was at the University of Bath, where I worked on the corporate political activity of tobacco companies.
I welcome applications from PhD students in any of my research interests.
Projects and supervisions
Research projects
An Inconsequential Measure of Pain? Corporate Crime, Enforcement Action, and Surrogates of Deterrence
Principal Investigator
Managing organisational unit
School for Policy StudiesDates
27/05/2024 to 19/12/2025
Publications
Recent publications
20/04/2023Executive Summary. Who Won? Who Lost? The Distributional Impact of COVID-19 Government Support for Business.
How Britain’s Covid support for big business entrenched inequality
Policy Brief: Who Won? Who Lost? The Distributional Impact of COVID-19 Government Support for Business.
Who Gained, who Lost? The Distributional Impact of COVID-19 Government Support for Business
Who Gained, who Lost? The Distributional Impact of COVID-19 Government Support for Business
The Institutionalization of Corporate Power within Policy
The Commercial Determinants of Health